Welcome to our dedicated page for Tat Techn SEC filings (Ticker: TATT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The TAT Technologies Ltd (NASDAQ: TATT) SEC filings page brings together the company’s regulatory disclosures as a foreign private issuer serving the commercial and military aerospace and ground defense industries. TAT files an annual report on Form 20-F and uses Form 6-K to furnish current reports that include financial results, contract announcements, shareholder meeting materials and other corporate information.
In recent Form 6-K filings, TAT has furnished unaudited condensed consolidated financial statements for quarterly periods, operating and financial review discussions, and press releases detailing second and third quarter 2025 results. These filings provide insight into revenue from products and services, gross profit, operating income and net income, as well as balance sheet data such as cash, inventory, loans and shareholders’ equity.
The company also uses 6-K reports to disclose public offerings of ordinary shares, including pricing, gross proceeds and intended use of proceeds, and to incorporate related prospectus supplements by reference to an effective Form F-3 registration statement. Additional filings cover matters such as the launch and closing of offerings, the exercise of underwriters’ options, and the results of Annual and Special General Meetings of shareholders, including approvals of proposals under Israeli company law and amendments to incentive plans.
Other 6-K submissions include company presentations, notices and proxy statements for shareholder meetings, supplemental information on incentive plan provisions, and governance updates such as changes in board composition. Through these filings, investors can follow how TAT’s OEM heat transfer solutions, aviation accessories, MRO services and jet engine component overhaul activities are reflected in its reported financial performance and capital markets activity.
On this page, AI-powered tools can help summarize lengthy 6-K exhibits and highlight key points from financial statements, shareholder meeting documents and offering-related filings, allowing users to quickly understand the implications of each new TATT submission to the U.S. Securities and Exchange Commission.
TAT Technologies Ltd. furnished a Form 6-K reporting the company's unaudited condensed consolidated financial statements as of
This submission supplies interim financial statements and management commentary for investors and regulators but does not, by itself, disclose line-item results or forward-looking numeric guidance within the furnished text. Readers seeking detailed amounts or changes over prior periods should consult the attached exhibits referenced in the filing for the full financial tables and the operating review.
TAT Technologies Ltd. (TATT) – Schedule 13G/A (Am. 3) dated 06/30/2025.
Y.D. More Investments Ltd. and affiliated entities/individuals report an aggregate 1,014,777 ordinary shares, equal to 7.9 % of the 12,810,893 shares outstanding. The filing is made under Rule 13d-1(c), indicating a passive investment.
- Subsidiary detail: More Mutual Funds Management – 781,852 shares (6.1 %); More Provident Funds & Pension – 210,530 (1.6 %); More Investment House Portfolio Management – 22,395 (0.2 %).
- All reporting persons possess shared voting power; only the asset-management subsidiaries have sole dispositive authority over their respective holdings.
- Individual controllers (Eli & Yosef Levy; Benjamin, Yosef, Michael & Dotan Meirov) and B.Y.M. More Investments are attributed the same 7.9 % stake through a voting agreement.
The group certifies the shares were not acquired to influence control of TAT Technologies.
Schedule 13G filing – TAT Technologies Ltd (TATT)
Phoenix Financial Ltd, a large Israeli financial group, has filed a Schedule 13G stating that on 27 June 2025 it beneficially owned 668,888.67 ordinary shares of TAT Technologies Ltd, representing 5.22 % of the company’s 12,807,656 shares outstanding. The holding is aggregated across several wholly-owned subsidiaries that manage proprietary and client funds. Phoenix reports zero sole voting or dispositive power; all authority is shared, signalling a passive investment intent under Rule 13d-1(c). Key sub-holdings include 355,512 shares in “Partnership for Israeli shares” (2.78 %) and 271,770.67 shares in “The Phoenix Investments House – trust funds” (2.12 %).
The group expressly disclaims acting as a control “group” and certifies that the position is not aimed at influencing management. While the disclosure introduces a new institutional owner above the 5 % threshold—potentially enhancing float liquidity and external confidence—it does not, at this stage, imply governance changes or activist engagement.
TAT Technologies Ltd. ("TATT") filed a Form 6-K detailing the completion of the underwriters’ over-allotment option connected to its May 29, 2025 public offering.
The option allowed Stifel and Truist, acting for the underwriting syndicate, to purchase an additional 622,500 ordinary shares (the “Option Shares”) at the public price of $26.00 per share, less underwriting discounts. Of these, the Company issued 242,298 new shares, while selling shareholders FIMI Opportunity V, L.P. and FIMI Israel Opportunity Five, L.P. sold 380,202 existing shares.
Financial impact: TATT generated gross proceeds of approximately $6.3 million from its portion of the Option Shares; it will not receive any proceeds from the selling shareholders’ portion. Management states that net proceeds will be used for “general corporate purposes, including working capital and capital expenditures.”
The Over-Allotment exercise brings total shares sold in the offering to 4,772,500 (1,867,298 newly issued by the Company and 2,905,202 sold by existing holders when including the previously closed base deal). All shares were offered pursuant to the effective Form F-3 (File No. 333-286699). The filing also references customary indemnification and termination clauses contained in the May 29 underwriting agreement, and attaches the legal opinion (Exhibit 5.1) and a press release dated June 26, 2025 (Exhibit 99.1).
Key takeaways for investors:
- Full option exercise suggests strong demand for TATT’s equity.
- TATT secures incremental liquidity of $6.3 million without additional debt.
- Issuance results in modest dilution to existing shareholders; exact percentage not disclosed in the filing.
TAT Technologies insider Igal Zamir has filed Form 144 declaring intention to sell 2,602 ordinary shares with an aggregate market value of $67,287.72 through broker Oppenheimer & Co. The proposed sale is scheduled for June 18, 2025, on the NASDAQ exchange.
The shares were originally acquired through an Employee Stock Option Plan on August 30, 2021, with a total acquisition of 24,614 shares. Payment was made in cash upon exercise of the options.
Notable recent trading activity by the same insider includes:
- June 9, 2025: Sold 22,279 shares for gross proceeds of $601,533
- June 16, 2025: Sold 22,012 shares for gross proceeds of $594,324
The company has approximately 10.94 million shares outstanding. This Form 144 filing represents the seller's declaration of no knowledge of undisclosed material adverse information regarding the company's operations.
TAT Technologies Ltd. (TATT) filed a Form 144 notice signaling a proposed insider sale under Rule 144 of the Securities Act. The filing covers 4,657 ordinary shares, to be routed through Oppenheimer & Co. Inc. on the NASDAQ, with an aggregate market value of approximately $120,430.02. The seller—whose name is not disclosed in the document—acquired the shares on 12 Dec 2022 via an Employee Stock Option Plan and intends to complete the sale on or about 18 Jun 2025, paying cash upon exercise. According to the filing, the issuer has 10,940,358 shares outstanding; therefore the planned disposition represents roughly 0.04 % of total shares, indicating a de minimis impact on float and potential dilution. No other sales by the same person have occurred during the past three months, and the filer certifies that no undisclosed material adverse information is known. Because Form 144 is a notice rather than a definitive sale, execution is contingent on market conditions and compliance with Rule 144 volume and timing limits. Overall, the disclosed transaction appears routine, involves a small fraction of outstanding equity, and does not, by itself, signal a meaningful change in TAT Technologies’ ownership structure or outlook.